These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Changes in pulmonary function in Parkinson's syndrome after treatment with L-DOPA. Langer H; Woolf CR Am Rev Respir Dis; 1971 Sep; 104(3):440-2. PubMed ID: 5098678 [No Abstract] [Full Text] [Related]
4. Some "minor" aspects of parkinsonism, especially pulmonary function. Paulson GD; Tafrate RH Neurology; 1970 Dec; 20(12):Suppl:14-7. PubMed ID: 5529912 [No Abstract] [Full Text] [Related]
5. Pulmonary function in chronic alcoholism. Banner AS Am Rev Respir Dis; 1973 Oct; 108(4):851-7. PubMed ID: 4741879 [No Abstract] [Full Text] [Related]
6. Abnormal ventilatory control in Parkinson's disease--further evidence for non-motor dysfunction. Seccombe LM; Giddings HL; Rogers PG; Corbett AJ; Hayes MW; Peters MJ; Veitch EM Respir Physiol Neurobiol; 2011 Dec; 179(2-3):300-4. PubMed ID: 21982817 [TBL] [Abstract][Full Text] [Related]
7. [Results of psychometic tests in 23 patients with Parkinson's disease after 6 months treatment with L-dopa]. Barbizet J; Duizabo P; Pasquier M Rev Neurol (Paris); 1972 Aug; 127(2):311-3. PubMed ID: 4666638 [No Abstract] [Full Text] [Related]
8. Some "minor" aspects of parkinsonism, especially pulmonary function. Paulson GD; Tafrate RH Neurology; 1970 Dec; 20(12):14-7. PubMed ID: 5531290 [No Abstract] [Full Text] [Related]
9. Upper airway muscles dysfunction and levodopa responsiveness in Parkinson's disease. Brescia Morra V; Polverino M; De Luca G; Landi P; Galdi A; Campanella G Acta Neurol (Napoli); 1992; 14(4-6):512-8. PubMed ID: 1293993 [TBL] [Abstract][Full Text] [Related]
10. Current concepts in the management of Parkinson's disease. Chapman WG West Indian Med J; 1974 Mar; 23(1):61-4. PubMed ID: 4456821 [No Abstract] [Full Text] [Related]
11. Oculomotor dysfunction in Parkinson's disease. Corin MS; Elizan TS; Siegel GJ Trans Am Neurol Assoc; 1970; 95():226-9. PubMed ID: 5514375 [No Abstract] [Full Text] [Related]
12. Pharmacodynamics of 3, 4-dihydroxyphenylalanine (Dopa) in Parkinson's disease. Van Woert MH Conn Med; 1970 Jun; 34(6):401-5. PubMed ID: 5431103 [No Abstract] [Full Text] [Related]
15. Modification of respiratory function parameters in patients with severe Parkinson's disease. De Pandis MF; Starace A; Stefanelli F; Marruzzo P; Meoli I; De Simone G; Prati R; Stocchi F Neurol Sci; 2002 Sep; 23 Suppl 2():S69-70. PubMed ID: 12548348 [TBL] [Abstract][Full Text] [Related]
16. [L-5-hydroxytryptophan(L-5-HTP) therapy of Parkinson's disease. 2]. Sano I; Taniguchi K Munch Med Wochenschr; 1972 Oct; 114(40):1717-9. PubMed ID: 4538893 [No Abstract] [Full Text] [Related]
17. Parkinson's disease and impaired chemosensitivity to hypoxia. Röggla G; Weber W; Röggla M Lancet; 2000 Dec; 356(9247):2099. PubMed ID: 11145518 [No Abstract] [Full Text] [Related]
18. Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa. Pal PK; Sathyaprabha TN; Tuhina P; Thennarasu K Mov Disord; 2007 Feb; 22(3):420-4. PubMed ID: 17230476 [TBL] [Abstract][Full Text] [Related]